The contribution of musculoskeletal factors to physical frailty: a cross-sectional study.


Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 26 01 2021
accepted: 11 10 2021
entrez: 2 11 2021
pubmed: 3 11 2021
medline: 4 11 2021
Statut: epublish

Résumé

Musculoskeletal conditions and physical frailty have overlapping constructs. We aimed to quantify individual contributions of musculoskeletal factors to frailty. Participants included 347 men and 360 women aged ≥60 yr (median ages; 70.8 (66.1-78.6) and 71.0 (65.2-77.5), respectively) from the Geelong Osteoporosis Study. Frailty was defined as ≥3, pre-frail 1-2, and robust 0, of the following; unintentional weight loss, weakness, low physical activity, exhaustion, and slowness. Measures were made of femoral neck BMD, appendicular lean mass index (ALMI, kg/m Overall, 54(15.6%) men and 62(17.2%) women were frail. In adjusted-binary logistic models, SI, ALMI and HGS were associated with frailty in men (OR = 0.73, 95%CI 0.53-1.01; OR=0.48, 0.34-0.68; and OR = 0.11, 0.06-0.22; respectively). Muscle measures (ALMI and HGS) contributed more to this association than did bone (SI) (AUROCs 0.77, 0.85 vs 0.71, respectively). In women, only HGS was associated with frailty in adjusted models (OR = 0.30 95%CI 0.20-0.45, AUROC = 0.83). In adjusted ordinal models, similar results were observed in men; for women, HGS and ALMI were associated with frailty (ordered OR = 0.30 95%CI 0.20-0.45; OR = 0.56, 0.40-0.80, respectively). Muscle deficits appeared to contribute more than bone deficits to frailty. This may have implications for identifying potential musculoskeletal targets for preventing or managing the progression of frailty.

Sections du résumé

BACKGROUND BACKGROUND
Musculoskeletal conditions and physical frailty have overlapping constructs. We aimed to quantify individual contributions of musculoskeletal factors to frailty.
METHODS METHODS
Participants included 347 men and 360 women aged ≥60 yr (median ages; 70.8 (66.1-78.6) and 71.0 (65.2-77.5), respectively) from the Geelong Osteoporosis Study. Frailty was defined as ≥3, pre-frail 1-2, and robust 0, of the following; unintentional weight loss, weakness, low physical activity, exhaustion, and slowness. Measures were made of femoral neck BMD, appendicular lean mass index (ALMI, kg/m
RESULTS RESULTS
Overall, 54(15.6%) men and 62(17.2%) women were frail. In adjusted-binary logistic models, SI, ALMI and HGS were associated with frailty in men (OR = 0.73, 95%CI 0.53-1.01; OR=0.48, 0.34-0.68; and OR = 0.11, 0.06-0.22; respectively). Muscle measures (ALMI and HGS) contributed more to this association than did bone (SI) (AUROCs 0.77, 0.85 vs 0.71, respectively). In women, only HGS was associated with frailty in adjusted models (OR = 0.30 95%CI 0.20-0.45, AUROC = 0.83). In adjusted ordinal models, similar results were observed in men; for women, HGS and ALMI were associated with frailty (ordered OR = 0.30 95%CI 0.20-0.45; OR = 0.56, 0.40-0.80, respectively).
CONCLUSION CONCLUSIONS
Muscle deficits appeared to contribute more than bone deficits to frailty. This may have implications for identifying potential musculoskeletal targets for preventing or managing the progression of frailty.

Identifiants

pubmed: 34724934
doi: 10.1186/s12891-021-04795-4
pii: 10.1186/s12891-021-04795-4
pmc: PMC8561908
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

921

Informations de copyright

© 2021. The Author(s).

Références

Osteoporos Int. 2013 Apr;24(4):1369-77
pubmed: 22814945
J Am Geriatr Soc. 2006 Jun;54(6):991-1001
pubmed: 16776798
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):441-6
pubmed: 22987796
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):690-697
pubmed: 32061063
Calcif Tissue Int. 2015 Dec;97(6):568-76
pubmed: 26319674
Front Endocrinol (Lausanne). 2019 Apr 24;10:255
pubmed: 31068903
Osteoporos Int. 2018 Oct;29(10):2191-2199
pubmed: 29947868
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Nestle Nutr Inst Workshop Ser. 2015;83:65-9
pubmed: 26484770
Calcif Tissue Int. 2020 Sep;107(3):220-229
pubmed: 32617612
BMC Musculoskelet Disord. 2017 Jan 26;18(1):46
pubmed: 28125982
Australas Radiol. 2004 Dec;48(4):473-5
pubmed: 15601326
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Med Sci Sports Exerc. 1991 Aug;23(8):974-9
pubmed: 1956274
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):278-86
pubmed: 26675566
Front Aging Neurosci. 2014 Jul 28;6:192
pubmed: 25120482
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Br Med Bull. 2010;95:139-59
pubmed: 20200012
Best Pract Res Clin Rheumatol. 2014 Jun;28(3):395-410
pubmed: 25481423
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
Osteoporos Int. 2014 Feb;25(2):763-8
pubmed: 24002542
Int J Epidemiol. 2012 Dec;41(6):1565-75
pubmed: 23283714
Bone. 2011 Apr 1;48(4):952-7
pubmed: 21195216
Aust N Z J Med. 1999 Apr;29(2):203-6
pubmed: 10342018
J Clin Densitom. 2006 Jul-Sep;9(3):309-14
pubmed: 16931349
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Age Ageing. 2017 Jul 1;46(4):635-641
pubmed: 27852598
Osteoporos Int. 2009 Nov;20(11):1837-46
pubmed: 19294329
Geriatr Nurs. 2009 Jan-Feb;30(1):64-70
pubmed: 19226689
Aging Clin Exp Res. 2017 Aug;29(4):721-728
pubmed: 27568018
BMC Geriatr. 2020 Jun 5;20(1):196
pubmed: 32503454
Osteoporos Int. 2010 Jun;21(6):909-17
pubmed: 19707703
J Gerontol. 1990 May;45(3):M82-8
pubmed: 2335723
Aust Fam Physician. 2017 Nov;46(11):849-853
pubmed: 29101922
Nephrol Dial Transplant. 1999 Aug;14(8):1917-21
pubmed: 10462271
Calcif Tissue Int. 2014 Apr;94(4):363-72
pubmed: 24390582

Auteurs

Monica C Tembo (MC)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia. mctembo@deakin.edu.au.

Mohammadreza Mohebbi (M)

Faculty of Health, Biostatistics Unit, Deakin University, Geelong, VIC, Australia.

Kara L Holloway-Kew (KL)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.

James Gaston (J)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.

Sophia X Sui (SX)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.

Sharon L Brennan-Olsen (SL)

School of Health and Social Development, Deakin University, Waterfront Geelong Campus, Geelong, VIC, Australia.
Institute for Health Transformation, Deakin University, Waterfront Geelong Campus, Geelong, VIC, Australia.
Department of Medicine-Western Health, The University of Melbourne, St Albans, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne, St Albans, VIC, Australia.

Lana J Williams (LJ)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.

Mark A Kotowicz (MA)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.
Department of Medicine-Western Health, The University of Melbourne, St Albans, VIC, Australia.
Barwon Health, Geelong, VIC, Australia.

Julie A Pasco (JA)

Epi-Centre for Healthy Ageing, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia.
Department of Medicine-Western Health, The University of Melbourne, St Albans, VIC, Australia.
Barwon Health, Geelong, VIC, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH